Clinical Perspectives on the Use of the GIP/GLP-1 Receptor Agonist Tirzepatide for the Treatment of Type-2 Diabetes and Obesity
Heyes, J., Palmer, L., Bremner, K
Similar content being viewed by others Background Pancreatic cancer is one of the few malignancies where the mortality is nearly equal to incidence, and is currently the fourth leading cause of cancer-related death in the United States
SmithCKVivekanandan-GiriATangCKnightJSMathewAPadillaRLet alNeutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus
319,324,325 Further investigations have shown that medications like benzbromarone and febuxostat can mitigate the advancement of chronic kidney disease and decrease serum uric acid levels in CKD patients, highlighting the potential advantages of treatments aimed at lowering uric acid levels
In standard laboratory models, this compound acts as an incredibly efficient carrier for copper ions, which are essential cofactors for numerous oxidative enzymes involved in cellular function